GSK Invest ApS: Financial statements 2022
CVR: 40362541
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GSK Invest ApS (CVR 40362541) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -11,632 and a net result of DKK 1,074,648 compared with DKK 924,236 the year before. Equity in the 2022 report amounted to DKK 4,177,730. The solvency ratio was 94.6%.
- Revenue
- DKK 0
- Gross Profit
- DKK -11,632
- Profit/Loss
- DKK 1,074,648
- Equity
- DKK 4,177,730
- Total Assets
- DKK 4,415,392
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -12K | 1.1M | 4.2M | - |
| 2021 | 0 | -11K | 924K | 3.1M | - |
| 2020 | - | -69K | 445K | 2.2M | 1 |
Official annual report
Keep an eye on GSK Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GSK Invest ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 924,236.
As of June 24, 2022, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of GSK Invest ApS.
As of June 24, 2022, DR CPH A/S has stepped down as auditor of GSK Invest ApS.
About GSK Invest ApS
GSK Invest ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gorm Schmidt Knudsen. The company is owned by Gorm Schmidt Knudsen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK -14,099 and a net result of DKK 938,720 compared with DKK 1,055,884 the year before. Equity in the 2025 report amounted to DKK 6,526,830.
